Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Ritchie

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Pharmacotherapy|March 7, 2012
Sustained impact of anticoagulant control achieved in an anticoagulation management service after transfer of management to the primary care physicianTammy J Bungard, Bruce Ritchie, Sipi Garg, et al.
BMJ Open|November 3, 2018
Anticoagulant therapies for acute venous thromboembolism: a comparison between those discharged directly from the emergency department versus hospital in two Canadian citiesTammy J Bungard, Bruce Ritchie, Jennifer Bolt, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 30, 2010
Management of hereditary angioedema: 2010 Canadian approachTom Bowen, John Brosz, Kristylea Brosz, et al.
BMJ Open|November 3, 2018
Management of acute venous thromboembolism among a cohort of patients discharged directly from the emergency departmentTammy J Bungard, Bruce Ritchie, Jennifer Bolt, et al.
Clinical Therapeutics|April 15, 2020
Use of Direct Oral Anticoagulants Versus Traditional Therapies for Acute Venous Thromboembolism After Direct Discharge From the Emergency Department or After Hospitalization: An Audit of 16 Canadian HospitalsTammy J Bungard, Bruce Ritchie, Jennifer Bolt, et al.
Frontiers in Immunology|July 30, 2024
Centralized care model for hereditary angioedema overcomes geographical barriersAshley Holmes, Cindy Srinivasan, Jack Borle, et al.
British Journal of Haematology|January 4, 2014
Activated prothrombin complex concentrate for dabigatran-associated bleedingSam Schulman, Bruce Ritchie, Jennifer K Goy, et al.
Biomaterials|August 10, 2007
A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine 2000 for plasmid delivery to bone marrow stromal cellsBaşak Açan Clements, Vanessa Incani, Cezary Kucharski, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 16, 2016
Safety and feasibility of red cell exchange for sickle cell disease across CanadaRichard Ward, David Barth, Stephen Couban, et al.
Journal of Clinical Immunology|September 21, 2011
Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter studyMichael Borte, Isabella Quinti, Annarosa Soresina, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Pharmacotherapy|March 7, 2012
Sustained impact of anticoagulant control achieved in an anticoagulation management service after transfer of management to the primary care physicianTammy J Bungard, Bruce Ritchie, Sipi Garg, et al.
BMJ Open|November 3, 2018
Anticoagulant therapies for acute venous thromboembolism: a comparison between those discharged directly from the emergency department versus hospital in two Canadian citiesTammy J Bungard, Bruce Ritchie, Jennifer Bolt, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 30, 2010
Management of hereditary angioedema: 2010 Canadian approachTom Bowen, John Brosz, Kristylea Brosz, et al.
BMJ Open|November 3, 2018
Management of acute venous thromboembolism among a cohort of patients discharged directly from the emergency departmentTammy J Bungard, Bruce Ritchie, Jennifer Bolt, et al.
Clinical Therapeutics|April 15, 2020
Use of Direct Oral Anticoagulants Versus Traditional Therapies for Acute Venous Thromboembolism After Direct Discharge From the Emergency Department or After Hospitalization: An Audit of 16 Canadian HospitalsTammy J Bungard, Bruce Ritchie, Jennifer Bolt, et al.
Frontiers in Immunology|July 30, 2024
Centralized care model for hereditary angioedema overcomes geographical barriersAshley Holmes, Cindy Srinivasan, Jack Borle, et al.
British Journal of Haematology|January 4, 2014
Activated prothrombin complex concentrate for dabigatran-associated bleedingSam Schulman, Bruce Ritchie, Jennifer K Goy, et al.
Biomaterials|August 10, 2007
A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine 2000 for plasmid delivery to bone marrow stromal cellsBaşak Açan Clements, Vanessa Incani, Cezary Kucharski, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 16, 2016
Safety and feasibility of red cell exchange for sickle cell disease across CanadaRichard Ward, David Barth, Stephen Couban, et al.
Journal of Clinical Immunology|September 21, 2011
Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter studyMichael Borte, Isabella Quinti, Annarosa Soresina, et al.
Pageof 7